CME Gr Q2 Adj. EPS $2.99 Beats $2.91 Estimate, Sales $1.706B Beat $1.685B Estimate
Share
Why It Matters
CME Group made a bit more money than people expected this quarter—both in profit per share and total sales. When a company beats what experts predicted, it's a good sign that the business is running well and growing.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.